Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Toxicity issues in the application of carbon nanotubes to biological systems.

Firme CP 3rd, Bandaru PR.

Nanomedicine. 2010 Apr;6(2):245-56. doi: 10.1016/j.nano.2009.07.003. Epub 2009 Aug 20. Review.

PMID:
19699321
2.

A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks.

Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL.

Crit Rev Toxicol. 2006 Mar;36(3):189-217. Review.

PMID:
16686422
3.

Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.

Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, Briand JP, Prato M, Bianco A, Kostarelos K.

J Am Chem Soc. 2005 Mar 30;127(12):4388-96.

PMID:
15783221
4.

SiRNA delivery with functionalized carbon nanotubes.

Varkouhi AK, Foillard S, Lammers T, Schiffelers RM, Doris E, Hennink WE, Storm G.

Int J Pharm. 2011 Sep 20;416(2):419-25. doi: 10.1016/j.ijpharm.2011.02.009. Epub 2011 Feb 12.

PMID:
21320582
5.

A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics.

Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, Stone V.

Nanotoxicology. 2010 Jun;4(2):207-46. doi: 10.3109/17435390903569639. Review.

PMID:
20795897
6.

Understanding the toxicity of carbon nanotubes.

Liu Y, Zhao Y, Sun B, Chen C.

Acc Chem Res. 2013 Mar 19;46(3):702-13. doi: 10.1021/ar300028m. Epub 2012 Sep 21.

PMID:
22999420
7.

[Nanotubes and occupational medicine].

Borrelli I.

G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):851-2. Review. Italian.

PMID:
18409997
8.

In vivo biodistribution, pharmacokinetics, and toxicology of carbon nanotubes.

Yang K, Liu Z.

Curr Drug Metab. 2012 Oct;13(8):1057-67. Review.

PMID:
22380009
9.

Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.

Foldvari M, Bagonluri M.

Nanomedicine. 2008 Sep;4(3):183-200. doi: 10.1016/j.nano.2008.04.003. Epub 2008 Jun 11. Review.

PMID:
18550450
10.

Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues.

Cui HF, Vashist SK, Al-Rubeaan K, Luong JH, Sheu FS.

Chem Res Toxicol. 2010 Jul 19;23(7):1131-47. doi: 10.1021/tx100050h. Review.

PMID:
20402485
11.

Carbon nanotube uptake and toxicity in the brain.

Zhang L, Alizadeh D, Badie B.

Methods Mol Biol. 2010;625:55-65. doi: 10.1007/978-1-60761-579-8_6.

PMID:
20422381
12.

Chapter 6 - Carbon nanotubes as substrates/scaffolds for neural cell growth.

Lee W, Parpura V.

Prog Brain Res. 2009;180:110-25. doi: 10.1016/S0079-6123(08)80006-4. Epub 2009 Dec 8. Review.

PMID:
20302831
13.

Functionalized carbon nanotubes in drug design and discovery.

Prato M, Kostarelos K, Bianco A.

Acc Chem Res. 2008 Jan;41(1):60-8. Epub 2007 Sep 15. Review.

PMID:
17867649
14.

Advances in use of functionalized carbon nanotubes for drug design and discovery.

Jain KK.

Expert Opin Drug Discov. 2012 Nov;7(11):1029-37. doi: 10.1517/17460441.2012.722078. Epub 2012 Sep 5. Review.

PMID:
22946637
15.

Toxicity of carbon nanotubes.

Wang J, Xu Y, Yang Z, Huang R, Chen J, Wang R, Lin Y.

Curr Drug Metab. 2013 Oct;14(8):891-9. Review.

PMID:
24016107
16.

Influence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes with human neuroblastoma cells.

Vittorio O, Raffa V, Cuschieri A.

Nanomedicine. 2009 Dec;5(4):424-31. doi: 10.1016/j.nano.2009.02.006. Epub 2009 Mar 31.

PMID:
19341817
17.

Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions.

Adeli M, Soleyman R, Beiranvand Z, Madani F.

Chem Soc Rev. 2013 Jun 21;42(12):5231-56. doi: 10.1039/c3cs35431h. Review.

PMID:
23443245
18.

Understanding the toxicity of carbon nanotubes in the environment is crucial to the control of nanomaterials in producing and processing and the assessment of health risk for human: a review.

Du J, Wang S, You H, Zhao X.

Environ Toxicol Pharmacol. 2013 Sep;36(2):451-62. doi: 10.1016/j.etap.2013.05.007. Epub 2013 May 24. Review.

PMID:
23770455
19.

Imaging methods for determining uptake and toxicity of carbon nanotubes in vitro and in vivo.

Nerl HC, Cheng C, Goode AE, Bergin SD, Lich B, Gass M, Porter AE.

Nanomedicine (Lond). 2011 Jul;6(5):849-65. doi: 10.2217/nnm.11.87. Review.

PMID:
21793676
20.

Carbon nanotube exploration in cancer cell lines.

Kesharwani P, Ghanghoria R, Jain NK.

Drug Discov Today. 2012 Sep;17(17-18):1023-30. doi: 10.1016/j.drudis.2012.05.003. Epub 2012 May 10.

PMID:
22579742

Supplemental Content

Support Center